# A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma

> **NCT05779592** · — · ACTIVE_NOT_RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 400 (estimated)

## Conditions studied

- Muscle-invasive Urothelial Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05779592
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-23
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-09-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05779592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05779592, "A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05779592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*